Skip to main content

Table 1 Willingness to use HIV self-testing by socio-demographic characteristics, HIV- and injection-related factors, and harm reduction utilization among people who inject drugs in Iran (2020)

From: Awareness and willingness to use HIV self-testing among people who inject drugs in Iran

Variable

Total N (%)a

Willingness to use HIV self-testing

Very low or low n (%)

High or very high n (%)

Prevalence ratio (95% CI)b

P value

Overall

2,252

594 (26.4)

1,658 (73.6)

–

–

Age at interview, mean years (SD)

40.1 (9.3)

39.9 (9.5)

40.2 (9.2)

–

–

Age, years

     

 < 30

246 (11.0)

67 (27.2)

179 (72.8)

1

0.893

 ≥ 30

1,992 (89.0)

527 (26.5)

1,465 (73.5)

1.01 (0.86, 1.18)

 

Gender

     

 Women

78 (3.5)

29 (37.2)

49 (62.8)

1

0.258

 Men

2,174 (96.5)

565 (26.0)

1,609 (74.0)

1.17 (0.89, 1.57)

 

Education

     

 Less than high school

1,572 (70.1)

443 (28.2)

1,129 (71.8)

1

0.141

 High school or more

671 (29.9)

150 (22.3)

521 (77.7)

1.08 (0.97, 1.19)

 

Marital Status

     

 Single

784 (35.9)

196 (25.0)

588 (75.0)

1

 

 Currently married

554 (25.4)

203 (36.6)

351 (63.4)

0.84 (0.74, 0.96)

0.012

 Divorced/widowed

846 (38.7)

181 (21.4)

665 (78.6)

1.04 (0.95, 1.17)

0.407

Current employment

     

 Unemployed

45 (2.4)

20 (44.4)

25 (55.6)

1

 

 Having a temporary job

1,513 (79.6)

387 (25.6)

1, 126 (74.4)

1.33 (0.90, 1.99)

0.184

 Having a permanent job

342 (18.0)

91 (26.6)

251 (73.4)

1.32 (0.87, 1.99)

0.148

HIV risk perception

     

 Very low or low

1,154 (64.7)

338 (29.3)

816 (70.7)

1

 

 Moderate or high

630 (35.3)

47 (7.5)

583 (92.5)

1.31 (1.18, 1.45)

< 0.001

Lifetime homelessness

     

 No

963 (43.0)

317 (32.9)

646 (67.1)

1

 

 Yes

1,275 (57.0)

275 (21.6)

1,000 (78.4)

1.17 (1.06, 1.29)

0.002

Lifetime incarceration

     

 No

740 (33.1)

257 (34.7)

483 (65.3)

1

 

 Yes

1,496 (66.9)

332 (22.2)

1,164 (77.8)

1.19 (1.07, 1.32)

0.001

Experience of stigma within healthcare settings

     

 Never

1,197 (55.0)

318 (26.6)

879 (73.4)

1

 

 Ever

980 (45.0)

265 (27.0)

715 (73.0)

0.99 (0.90, 1.10)

0.898

Experience of stigma from family/friends

     

 Never

357 (15.9)

127 (35.6)

230 (64.4)

1

 

 Ever

1,888 (84.1)

466 (24.7)

1,422 (75.3)

1.16 (1.02, 1.34)

0.028

Duration of injection, year

     

 < 5

545 (25.1)

224 (41.1)

321 (58.9)

1

 

 5–10

555 (25.5)

161 (29.0)

394 (71.0)

1.20 (1.04, 1.40)

0.013

 > 10

1,073 (49.4)

187 (17.4)

886 (82.6)

1.40 (1.23, 1.59)

< 0.001

Injection frequency, last 3 months

     

 Monthly or less

901 (40.3)

299 (33.2)

602 (66.8)

1

 

 Weekly or daily

1,333 (59.7)

282 (21.2)

1,051 (78.8)

1.18 (1.07, 1.30)

0.001

Receptive needle/syringe sharing, last 3 months

     

 No

1,935 (95.9)

525 (27.1)

1,410 (72.9)

1

 

 Yes

83 (4.1)

20 (24.1)

63 (75.9)

1.04 (0.81, 1.34)

0.751

Public injecting, last 12 months

     

 No

593 (29.3)

212 (35.7)

381 (64.3)

1

 

 Yes

1,433 (70.7)

351 (24.5)

1,082 (75.5)

1.17 (1.04, 1.32)

0.007

Utilizing needle exchange program, last 12 months

     

 No

208 (12.0)

78 (37.5)

130 (62.5)

1

 

 Yes

1,522 (88.0)

373 (24.5)

1,149 (75.5)

1.20 (1.01, 1.44)

0.041

  1. aN for each variable may not add up to total sample (2,252) due to missing value
  2. bPrevalence ratios (PR), 95% confidence intervals (CIs), and P value were obtained from bivariable modified Poisson regression